Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hi-Tech Lawsuit Calls FDA DMAA Enforcement “Bullying Tactics”

This article was originally published in The Tan Sheet

Executive Summary

Hi-Tech Pharmaceuticals files a lawsuit in federal court after receiving an administrative detention order from FDA to stop distributing its DMAA-containing products. The firm argues FDA should conduct a rulemaking to propose banning DMAA rather than ordering firms to stop using it.

Advertisement

Related Content

Hi-Tech Tangles With FDA Again: Plans Litigation To Keep DMHA Available
Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements
Hi-Tech DMAA Ruling, Recalls: Health And Wellness Industry News
FDA Chases Another Synthetic Stimulant Off Supplement Ingredient Menu
FDA Chases Another Synthetic Stimulant Off Supplement Ingredient Menu
BMPEA Is A Misbranding Issue For FDA, While Critics Ask Other Questions
BMPEA Is A Misbranding Issue For FDA, While Critics Ask Other Questions
FDA Ushers Out Known DMAA, Closes Dietary Ingredient Door
FDA Using “All Available Tools” To Remove DMAA From Market
Hi-Tech Prosecution Offers FDA Model For Pursuing Bad Actors – Lawyer

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106721

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel